Household Clusters of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Suzhou, China

被引:0
|
作者
Yao, Lin [1 ]
Tang, Peijun [1 ]
Jiang, Hui [2 ]
Gu, Binbin [3 ]
Xu, Ping [4 ]
Wang, Xiafang [1 ]
Yu, Xin [1 ]
Zhang, Jianping [1 ]
Pang, Yu [2 ]
Wu, Meiying [1 ]
机构
[1] Soochow Univ, Peoples Hosp Suzhou 5, Dept Pulm, Affiliated Infect Dis Hosp, Suzhou 215000, Peoples R China
[2] Capital Med Univ, Beijing TB & Thorac Tumor Res Inst, Beijing Key Lab Drug Resistant TB Res, Beijing Chest Hosp,Dept Bacteriol & Immunol, Beijing 101149, Peoples R China
[3] Soochow Univ, Peoples Hosp Suzhou 5, Intens Care Unit, Affiliated Infect Dis Hosp, Suzhou 215000, Peoples R China
[4] Soochow Univ, Peoples Hosp Suzhou 5, Dept Clin Lab, Affiliated Infect Dis Hosp, Suzhou 215000, Peoples R China
关键词
VIRULENCE;
D O I
10.1155/2021/5565549
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Objectives. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an emerging virus causing substantial morbidity and mortality worldwide. We performed a cross-sectional investigation of SARS-CoV-2 clusters in Suzhou to determine the transmissibility of the virus among close contacts and to assess the demographic and clinical characteristics between index and secondary cases. Methods. We review the clustered patients with SARS-CoV-2 infections in Suzhou between 22 January and 29 February 2020. The demographic and clinical characteristics were compared between index and secondary cases. We calculated the basic reproduction number (R-0) among close contacts with SLI model. Results. By 22 February, 87 patients with SARS-CoV-2 infection were reported, including 50 sporadic and 37 clustered cases, who were generated from 13 clusters. On admission, 5 (20.8%) out of 24 secondary cases were asymptomatic. The male ratio of index cases was significantly higher than that of secondary cases. Additionally, the index cases were more likely to have fever and increased CRP levels than the secondary cases. The R-0 values of clusters displayed a significantly declining trend over time for all clusters. The relative risk of infection in blood-related contacts of cases versus unrelated contacts was 1.60 for SARS-CoV-2 (95% CI: 0.42-2.95). Conclusions. In conclusion, SARS-CoV-2 has great person-to-person transmission capability among close contacts. The secondary cases are more prone to have mild symptoms than index cases. There is no increased RR of secondary infection in blood relatives versus unrelated contacts. The high rate of asymptomatic SARS-CoV-2 infections highlights the urgent need to enhance active case finding strategy for early detection of infectious patients.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] The landscape of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genomic mutations
    Lippi, Giuseppe
    Henry, Brandon M.
    JOURNAL OF LABORATORY AND PRECISION MEDICINE, 2022, 7
  • [32] Variants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Vaccine Effectiveness
    Tulimilli, SubbaRao, V
    Dallavalasa, Siva
    Basavaraju, Chaithanya G.
    Rao, Vinay Kumar
    Chikkahonnaiah, Prashanth
    Madhunapantula, SubbaRao, V
    Veeranna, Ravindra P.
    VACCINES, 2022, 10 (10)
  • [33] Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) by Mass Spectrometry
    Wandernoth, Petra
    Kriegsmann, Katharina
    Groh-Mohanu, Cristina
    Daeumer, Martin
    Gohl, Peter
    Harzer, Oliver
    Kriegsmann, Mark
    Kriegsmann, Joerg
    VIRUSES-BASEL, 2020, 12 (08):
  • [34] The Aerosolization of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Phase I
    Ayuso, Sullivan A.
    Soriano, Ian S.
    Augenstein, Vedra A.
    Shao, Jenny M.
    JOURNAL OF SURGICAL RESEARCH, 2022, 274 : 108 - 115
  • [35] Testicular Changes Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
    Iakymenko, Oleksii A.
    Ramasamy, Ranjith
    Kryvenko, Oleksandr N.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2021, 145 (07) : 781 - 781
  • [36] Testicular Changes Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
    Flaifel, Abdallah
    Guzzetta, Melissa
    Occidental, Michael
    Najari, Bobby B.
    Melamed, Jonathan
    Thomas, Kristen M.
    Deng, Fang-Ming
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2021, 145 (01) : 8 - 9
  • [37] Coinfection of Influenza Virus and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2)
    Wu, Di
    Lu, Jianyun
    Ma, Xiaowei
    Liu, Qun
    Wang, Dedong
    Gu, Yuzhou
    Li, Yongguang
    He, Weiyun
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2020, 39 (06) : E79 - E79
  • [38] Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Environmental Contamination and Childbirth
    Hermesch, Amy C.
    Horve, Patrick F.
    Edelman, Alison
    Dietz, Leslie
    Constant, David
    Fretz, Mark
    Messer, William B.
    Martindale, Robert
    Van den Wymelenberg, Kevin
    OBSTETRICS AND GYNECOLOGY, 2020, 136 (04): : 827 - 829
  • [39] Overview of Hydroxychloroquine and Remdesivir on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
    Kabi, Arup K.
    Pal, Maynak
    Gujjarappa, Raghuram
    Malakar, Chandi C.
    Roy, Mithun
    JOURNAL OF HETEROCYCLIC CHEMISTRY, 2023, 60 (02) : 165 - 182
  • [40] Magnitude and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Household Transmission: A Longitudinal Cohort Study
    Kelly, J. Daniel
    Lu, Scott
    Anglin, Khamal
    Garcia-Knight, Miguel
    Pineda-Ramirez, Jesus
    Goldberg, Sarah A.
    Tassetto, Michel
    Zhang, Amethyst
    Donohue, Kevin
    Davidson, Michelle C.
    Romero, Mariela
    Sanchez, Ruth Diaz
    Djomaleu, Manuella
    Mathur, Sujata
    Chen, Jessica Y.
    Forman, Carrie A.
    Servellita, Venice
    Montejano, Rubi D.
    Shak, Joshua R.
    Rutherford, George W.
    Deeks, Steven G.
    Abedi, Glen R.
    Rolfes, Melissa A.
    Saydah, Sharon
    Briggs-Hagen, Melissa
    Peluso, Michael J.
    Chiu, Charles
    Midgley, Claire M.
    Andino, Raul
    Martin, Jeffrey N.
    CLINICAL INFECTIOUS DISEASES, 2022, 75 : S193 - S204